Novel hematological biomarkers predict survival in renal cell carcinoma patients treated with nephrectomy.
Conclusions: Only dNLR was an independent prognostic factor for CSS and OS. Nevertheless, our study indicates that all examined complete blood count-based biomarkers may be useful tools in managing RCC patients treated with a surgical approach.
PMID: 32863995 [PubMed]
Source: Archives of Medical Science - Category: General Medicine Tags: Arch Med Sci Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Carcinoma | General Medicine | Hematology | Kidney Cancer | Nephrectomy | Renal Cell Carcinoma | Science | Study